Cargando…
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways
Glioblastoma (GB) is a tumor of the central nervous system characterized by high proliferation and invasiveness. The standard treatment for GB includes radiotherapy and chemotherapy; however, new therapies are needed. Particular attention was given to the role of histone methyltransferase enhancer o...
Autores principales: | Scuderi, Sarah Adriana, Filippone, Alessia, Basilotta, Rossella, Mannino, Deborah, Casili, Giovanna, Capra, Anna Paola, Chisari, Giulia, Colarossi, Lorenzo, Sava, Serena, Campolo, Michela, Esposito, Emanuela, Paterniti, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694970/ https://www.ncbi.nlm.nih.gov/pubmed/36430394 http://dx.doi.org/10.3390/ijms232213915 |
Ejemplares similares
-
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
por: Mannino, Deborah, et al.
Publicado: (2023) -
The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion
por: Casili, Giovanna, et al.
Publicado: (2021) -
Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
por: Basilotta, Rossella, et al.
Publicado: (2023) -
Role of Calixarene in Chemotherapy Delivery Strategies
por: Basilotta, Rossella, et al.
Publicado: (2021) -
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma
por: Scuderi, Sarah Adriana, et al.
Publicado: (2021)